medigraphic.com
SPANISH

Neurología, Neurocirugía y Psiquiatría

ISSN 0028-3851 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 2

<< Back Next >>

Rev Neurol Neurocir Psiquiat 2023; 51 (2)

Rituximab

Ortiz MJ
Full text How to cite this article 10.35366/113421

DOI

DOI: 10.35366/113421
URL: https://dx.doi.org/10.35366/113421

Language: Spanish
References: 3
Page: 89-90
PDF size: 82.34 Kb.


Key words:

No keywords




REFERENCES

  1. Ribeiro SJ, Mora L, Mulero P, Sastre-Garriga J, Montalban X. Rituximab: eficacia, efectividad y seguridad en el tratamiento de la esclerosis múltiple. Rev Neurol. 2018; 66 (1): 25-32.

  2. Salzer J, Svenningsson R, Alping P, Novakova L, Bjorck A, Fink K, et al. Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy. Neurology. 2016; 87 (20): 2074-2081.

  3. Chisari CG, Sgarlata E, Arena S, Toscano S, Luca M, Patti F. Rituximab for the treatment of multiple sclerosis: a review. J Neurol. 2022; 269 (1): 159-183.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Neurol Neurocir Psiquiat. 2023;51